Strawberry Fields Reit Inc

Strawberry Fields Reit Inc(STRW)股票分析

$13.620

-0.274 (-2.01%)收盤時

Loading chart…
High
13.980
Open
13.920
VWAP
13.67
Vol
40.97K
Mkt Cap
70.09M
Low
13.410
Amount
560.10K
EV/EBITDA, TTM
9.43

Strawberry Fields REIT, Inc. is a self-administered real estate investment trust. The Company is engaged in the ownership, acquisition, development and leasing of skilled nursing and certain other healthcare-related properties. The Company’s portfolio includes approximately 142 healthcare facilities with an aggregate of 15,500+ beds, located throughout the states of Arkansas, Illinois, Indiana, Kansas, Kentucky, Missouri, Ohio, Oklahoma, Tennessee and Texas. The 142 healthcare facilities comprise 130 skilled nursing facilities, 10 assisted living facilities, and two long-term acute care hospitals. Each property is operated as a healthcare facility by a licensed operator, which may be the tenant or a separate operator. Its portfolio includes Infinity Healthcare of Illinois, BRIA Health Services, Infinity Healthcare of Indiana, Infinity Healthcare of Tennessee, The Tide Group, Creative Solutions, Continent Health Care, Zahav of Des Plaines and others.

AI analysis of Strawberry Fields Reit Inc (STRW)

hold

Strawberry Fields REIT (STRW) is currently trading at $13.62, which is below the analyst price targets of $15 to $16, indicating potential upside. However, the RSI is at 39.617, suggesting the stock is nearing oversold territory, but it has not yet triggered a buy signal. The recent earnings report showed a miss with EPS of $0.32 against an estimate of $0.34, which may dampen investor sentiment in the short term. The main risk is the company's high debt-to-equity ratio of 2459.58%, which poses significant financial leverage concerns.

估值指標

The current forward P/E ratio for Strawberry Fields Reit Inc (STRW) is 20.75, compared to its 5-year average forward P/E of 10.91.

Forward P/E

Fair
5Y Average P/E
10.91
Current P/E
20.75
高估
26.72
低估
-4.90

Forward EV/EBITDA

Overvalued
5Y Average EV/EBITDA
6.36
Current EV/EBITDA
9.43
高估
7.99
低估
4.74

Forward P/S

Strongly Overvalued
5Y Average P/S
0.88
Current P/S
4.51
高估
1.75
低估
0.00

Alphio AI Price Scenarios for STRW

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%STRW

$14.40

情境價格

B

Base

Base · 50%STRW

$14.14

情境價格

B

Bear

Bear · 25%STRW

$12.67

情境價格

事件時間軸

2026-08-06 (ET)

17:30:00

Company Successfully Closes Corporate Credit Facility

2026-04-15 (ET)

16:10:00

Strawberry Fields REIT Files $200M Mixed Securities Shelf

2025-12-31 (ET)

06:50:00

Strawberry Fields REIT Emphasizes Disciplined Expansion Strategy at NobleCon21

2025-09-11 (ET)

08:32:34

Strawberry Fields REIT Appoints IBN for Corporate Communications Services

2025-09-02 (ET)

06:32:04

Strawberry Fields REIT purchases Missouri facility for $5.3 million

資訊

STRW FAQ — answered by Alphio AI

Strawberry Fields REIT, Inc. is a self-administered real estate investment trust. The Company is engaged in the ownership, acquisition, development and leasing of skilled nursing and certain other healthcare-related properties. The Company’s portfolio includes approximately 142 healthcare facilities with an aggregate of 15,500+ beds, located throughout the states of Arkansas, Illinois, Indiana, Kansas, Kentucky, Missouri, Ohio, Oklahoma, Tennessee and Texas. The 142 healthcare facilities comprise 130 skilled nursing facilities, 10 assisted living facilities, and two long-term acute care hospitals. Each property is operated as a healthcare facility by a licensed operator, which may be the tenant or a separate operator. Its portfolio includes Infinity Healthcare of Illinois, BRIA Health Services, Infinity Healthcare of Indiana, Infinity Healthcare of Tennessee, The Tide Group, Creative Solutions, Continent Health Care, Zahav of Des Plaines and others. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

Strawberry Fields REIT (STRW) is currently trading at $13.62, which is below the analyst price targets of $15 to $16, indicating potential upside. However, the RSI is at 39.617, suggesting the stock is nearing oversold territory, but it has not yet triggered a buy signal. The recent earnings report showed a miss with EPS of $0.32 against an estimate of $0.34, which may dampen investor sentiment in the short term. The main risk is the company's high debt-to-equity ratio of 2459.58%, which poses significant financial leverage concerns.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始